In Brief: E-Z-EM/Abbott
This article was originally published in The Gray Sheet
Executive Summary
E-Z-EM/Abbott: E-Z-EM's Enteric Products, Inc. subsidiary reaches marketing agreement with Abbott Laboratories covering serum and whole-blood versions of physician's office tests (co-developed by EPI and SmithKline Diagnostics) for the detection of H. Pylori. Under the agreement, Abbott will market the tests, which are manufactured by SKD, under the name FlexPack HP in China, India, other Asian countries, Eastern Europe, and parts of the Middle East and Africa. SKD also markets the tests under the name FlexSure HP in the U.S. and other "selected" regions. In return, EPI will receive revenue from: product sales directly to Abbott; royalties from product sales to Abbott by SKD and from SKD to distributors and end-users; and sales of EPI's HM-CAP antigen to SKD for use in the tests...